2. Tingbo Liang, Shiguo Xu, Jun Yu, Kezhen Shen, Donglin Li, and Shusen Zheng. Activation Pattern of Mitogen-Activated Protein Kinases in Early Phase of Different Size Liver Isografts in Rats. Liver Transplantation, 2005; 11(12): 1527-1532. (Corresponding Author)
3.W Wei-lin, J Jing, Z Shu-sen, W Li-hua, L Ting-bo, Y Song-feng, and Y Sheng, Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients Liver Transpl 2006, 12(5): 775-80. (Corresponding Author)
4.Sheng Yan, Zhenhua Tu, Weifeng Lu, Qiyi Zhang, Jiangjuan He, Zhiwei Li, Yi Shao, Weilin Wang, Min Zhang, and Shusen Zheng Clinical Utility of an Automated Pupillometer for Assessing and Monitoring Recipients of Liver Transplantation Liver Transpl 15:1718-1727, 2009 (Corresponding Author)
5. Yu S, Wu L, Jin J, Yan S, Jiang G, Xie H, Zheng S. Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. Transplantation. 2006;81(1):46-51. (Corresponding Author)
6. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation. 2008 Jun 27;85(12):1726-32.
7.Liang TB, Li DL, Liang L, Li JJ, Bai XL, Yu W, Wang WL, Shen Y, Zhang M, Zheng SS.Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells.Transplantation. 2008 Mar 27;85(6):863-9 (Corresponding Author)
8.Xu X, Ling Q, Zhang M, Gao F, He Z, You J, Zheng S. Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience. Transplantation. 2009 May 27;87(10):1514-9. (Corresponding Author)
9.S Yin, J Li, C Hu, X Chen, M Yao, M Yan, G Jiang, C Ge, H Xie, D Wan, S Yang, S Zheng, and J Gu. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity., Int J Cancer 2007, 120(7): 1444-50. (Corresponding Author)
10.Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.Predictive Value of Expression and Promoter Hypermethylation of XAF1 in Hepatitis B Virus-Associated Hepatocellular Carcinoma Treated with Transplantation. Ann Surg Oncol. 2008 Dec;15(12):3494-502. (Corresponding Author)
省部級(jí)以上獲獎(jiǎng)情況（第一完成人)：
1.胰十二指腸及腎一期移植 1994年 浙江省科技進(jìn)步一等獎(jiǎng)
2.胰十二指腸及腎一期移植 gydjdsj.org.cn1996年 國家科技進(jìn)步二等獎(jiǎng)
3.肝腎聯(lián)合移植的臨床研究 2000年 浙江省科技進(jìn)步一等獎(jiǎng)
4.鄭樹森（個(gè)人) 2003年 浙江省科技技術(shù)重大貢獻(xiàn)獎(jiǎng)
5.原位肝移植治療終末期肝病的應(yīng)用與推廣研究2005年 浙江省科技進(jìn)步一等獎(jiǎng)
6.供體過繼免疫在肝臟移植中應(yīng)用研究 2005年 中華醫(yī)學(xué)科技三等獎(jiǎng)
7.活體肝移植創(chuàng)新技術(shù)研究及臨床應(yīng)用2007年 浙江省科技進(jìn)步一等獎(jiǎng)
8肝移植技術(shù)創(chuàng)新體系的建立與推廣應(yīng)用 2008年 國家科技進(jìn)步二等獎(jiǎng)
9.肝移植圍手術(shù)期腎功能評(píng)估及其預(yù)警價(jià)值研究 2009年 浙江省科技進(jìn)步一等獎(jiǎng)
上一頁 [1] [2] [3] [4] 下一頁
